These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9331804)

  • 1. ELISA for detecting proteinases produced by group A streptococci.
    Huang J; Diepeveen J; Bielecki J
    Adv Exp Med Biol; 1997; 418():937-9. PubMed ID: 9331804
    [No Abstract]   [Full Text] [Related]  

  • 2. The human antibody response to streptococcal C5a peptidase.
    O'Connor SP; Darip D; Fraley K; Nelson CM; Kaplan EL; Cleary PP
    J Infect Dis; 1991 Jan; 163(1):109-16. PubMed ID: 1984457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme-linked immunosorbent assay for group A Streptococcal anti-DNase B in human sera, using recombinant proteins - Comparison to the DNA methyl green micromethod.
    Das S; Dileepan T; Johnson DR; Kaplan EL; Patrick Cleary P
    J Immunol Methods; 2017 Dec; 451():111-117. PubMed ID: 28939394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The flesh-eating bacterium: what's next?
    Stevens DL
    J Infect Dis; 1999 Mar; 179 Suppl 2():S366-74. PubMed ID: 10081509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on the measurement of antibody against an extracellular protein associated with nephritogenic streptococci by using the enzyme-linked immunosorbent assay (ELISA)].
    Quan JW; Todome Y; Ohkuni H
    Nihon Ika Daigaku Zasshi; 1984 Jun; 51(3):339-45. PubMed ID: 6378960
    [No Abstract]   [Full Text] [Related]  

  • 6. Is streptolysin S of group A streptococci a virulence factor?
    Ginsburg I
    APMIS; 1999 Dec; 107(12):1051-9. PubMed ID: 10660134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive group A streptococcal disease. Association with a lack of anti-exotoxin antibodies.
    Mascini EM; Hazenberg MM; van Dalen A; Verhoef-Verhage LA; van Leeuwen NJ; Verhoef J; van Dijk H
    Adv Exp Med Biol; 1997; 418():921-2. PubMed ID: 9331799
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune response to group A streptococcal C5a peptidase in children: implications for vaccine development.
    Shet A; Kaplan EL; Johnson DR; Cleary PP
    J Infect Dis; 2003 Sep; 188(6):809-17. PubMed ID: 12964111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment.
    Stevens DL
    Emerg Infect Dis; 1995; 1(3):69-78. PubMed ID: 8903167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Necrotizing soft tissue infections caused by Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis of groups C and G in western Norway.
    Bruun T; Kittang BR; de Hoog BJ; Aardal S; Flaatten HK; Langeland N; Mylvaganam H; Vindenes HA; Skrede S
    Clin Microbiol Infect; 2013 Dec; 19(12):E545-50. PubMed ID: 23795951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remote group A β-hemolytic Streptococcal fasciitis and myositis: a rare complication from hematogenous spread of Streptococcal pharyngitis.
    Zink JU; Morse BC; Vercruysse GA; Dente CJ; Jones YR; Feliciano DV
    Am Surg; 2013 Sep; 79(9):e296-7. PubMed ID: 24069966
    [No Abstract]   [Full Text] [Related]  

  • 12. Study on serum antistreptococcal esterase among school children.
    Takeuchi T; Inoue J; Onishi T; Kawakita S
    Jpn Circ J; 1984 Dec; 48(12):1325-9. PubMed ID: 6392591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo Streptococcus pyogenes C5a peptidase activity: analysis using transposon- and nitrosoguanidine-induced mutants.
    O'Connor SP; Cleary PP
    J Infect Dis; 1987 Sep; 156(3):495-504. PubMed ID: 3039012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of streptococcal proteinase in acute post-streptococcal glomerulonephritis.
    Cu GA; Mezzano S; Zabriskie JB
    Adv Exp Med Biol; 1997; 418():137-40. PubMed ID: 9331617
    [No Abstract]   [Full Text] [Related]  

  • 15. Antistreptococcal esterase distribution in healthy individuals.
    Igari J; Kosakai N; Shibazaki S
    Jpn Circ J; 1984 Dec; 48(12):1334-7. PubMed ID: 6392593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Necrotising fasciitis and myositis that originated from gastrointestinal bacterial infection: two fatal cases.
    Fujioka M; Nishimura G; Miyazato O; Yamamoto T; Okamoto F; Tsunenori K
    Scand J Plast Reconstr Surg Hand Surg; 2003; 37(4):239-42. PubMed ID: 14582759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with C5a peptidase from either group A or B streptococci enhances clearance of group A streptococci from intranasally infected mice.
    Cleary PP; Matsuka YV; Huynh T; Lam H; Olmsted SB
    Vaccine; 2004 Oct; 22(31-32):4332-41. PubMed ID: 15474726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superantigens and streptococcal toxic shock syndrome.
    Proft T; Sriskandan S; Yang L; Fraser JD
    Emerg Infect Dis; 2003 Oct; 9(10):1211-8. PubMed ID: 14609454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assay for antibodies to group C and G streptococcal carbohydrate by enzyme-linked immunosorbent assay.
    Ayoub EM; Hawthorne T; Miller J
    J Lab Clin Med; 1986 Mar; 107(3):204-9. PubMed ID: 3512746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of group A streptococci in mice and efficacy of locally administered streptococcal vaccines.
    Bronze MS; McKinsey DS; Beachey EH; Dale JB
    Trans Assoc Am Physicians; 1988; 101():88-92. PubMed ID: 3077732
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.